Abstract:Microvascular loss is one of the most important characteristics of skin aging, and abundant microvascular plays a key role in preserving skin health. Given the involvement of lycopene (Ly) in raising IGF-1 and decreasing AGEs when combined with metformin, as well as the importance of SIRT1 in cardiovascular function preservation, the present study was undertaken to investigate whether lycopene can delay aging by improving insulin resistance and regulating SIRT1 expression. In D-gal-induced aging skin cells, Ly reduced the content of ROS, β-galactosidase, and AGEs, while increasing the content of ATP, NAD+/NADH, and mitochondrial membrane potential (MMP). Furthermore, the expression of Fibrillin-I and VEGF was increased in aged PRSFs. LC-MS non-targeted cell metabolomics demonstrated the mechanism by which lycopene protects aging skin cells, and KEGG predicted the pathways involved. Based on a D-gal-induced skin aging model in rats, lycopene could reverse insulin resistance and promote micro-angiogenesis to protect aging skin. In vivo, aged rats exhibited signs of reduced capillary density and blood flow, aging skin, mitochondrial disorder, and insulin resistance. Following lycopene intervention, these phenomena were reversed. Meanwhile, insulin pathway protein, VEGF, and SIRT1 protein expression data showed that lycopene might reverse insulin resistance and promote microvascular renewal to protect aging skin. To conclude, all data demonstrated that lycopene might reverse insulin resistance via SIRT1 during skin aging and promote microvascular neovascularization to protect aging skin.

Lycopene ameliorates skin aging by regulation of the insulin resistance pathway and activation of SIRT1